References

Prevalence of immunosuppression among US adults

10.1001/jama.2023.28019 · ExternalCitation · doi-reference

Antibody response to respiratory syncytial virus vaccination in immunocompromised persons

10.1001/jama.2024.25395 · ExternalCitation · doi-reference

RSV vaccine effectiveness against hospitalization among US adults aged 60 years or older during 2 seasons

10.1001/jama.2025.15896 · ExternalCitation · doi-reference

Estimated Medicaid spending on original and citrate-free adalimumab from 2014 through 2021

10.1001/jamainternmed.2022.6299 · ExternalCitation · doi-reference

Durability of respiratory syncytial virus vaccine effectiveness among US veterans

10.1001/jamainternmed.2025.6355 · ExternalCitation · doi-reference

Burden of respiratory syncytial virus-associated hospitalizations in US adults, October 2016 to September 2023

10.1001/jamanetworkopen.2024.44756 · ExternalCitation · doi-reference

Estimated vaccine effectiveness for respiratory syncytial virus-related lower respiratory tract disease

10.1001/jamanetworkopen.2024.50832 · ExternalCitation · doi-reference

Respiratory syncytial virus vaccination in allogeneic hematopoietic stem cell transplant recipients

10.1001/jamanetworkopen.2025.33828 · ExternalCitation · doi-reference

Effectiveness and safety of respiratory syncytial virus vaccine for US adults aged 60 years or older

10.1001/jamanetworkopen.2025.8322 · ExternalCitation · doi-reference

Two-sided confidence intervals for the single proportion: comparison of seven methods

10.1002/(sici)1097-0258(19980430)17:8<857::aid-sim777>3.0.co;2-e · ExternalCitation · doi-reference

Respiratory syncytial virus sequelae among adults in high-income countries: a systematic literature review and meta-analysis

10.1007/s40121-024-00974-7 · ExternalCitation · doi-reference

A pragmatic individually randomized trial to evaluate bivalent RSV prefusion F protein-based vaccine effectiveness for preventing RSV hospitalizations in adults aged 60 years or above (DAN-RSV): rationale and trial design

10.1016/j.ahj.2025.07.068 · ExternalCitation · doi-reference

Respiratory syncytial virus prefusion F3 vaccine in lung transplant recipients elicits CD4+ T cell response in all vaccinees

10.1016/j.ajt.2025.03.025 · ExternalCitation · doi-reference

Safety and immunogenicity of adjuvanted respiratory syncytial virus vaccine in high-risk transplant recipients: an interventional cohort study

10.1016/j.cmi.2025.09.013 · ExternalCitation · doi-reference

Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis

10.1016/s0140-6736(24)01738-0 · ExternalCitation · doi-reference

Community-acquired respiratory virus infections in patients with haematological malignancies or undergoing haematopoietic cell transplantation: updated recommendations from the 10th European Conference on Infections in leukaemia

10.1016/s1473-3099(25)00365-2 · ExternalCitation · doi-reference

Vaccine effectiveness of a bivalent respiratory syncytial virus (RSV) pre-F vaccine against RSV-associated hospital admission among adults aged 75–79 years in England: a multicentre, test-negative, case-control study

10.1016/s1473-3099(25)00546-8 · ExternalCitation · doi-reference

Respiratory syncytial virus infection in elderly and high-risk adults

10.1056/nejmoa043951 · ExternalCitation · doi-reference

Respiratory syncytial virus prefusion F protein vaccine in older adults

10.1056/nejmoa2209604 · ExternalCitation · doi-reference

Efficacy and safety of a bivalent RSV prefusion F vaccine in older adults

10.1056/nejmoa2213836 · ExternalCitation · doi-reference

RSV prefusion F vaccine for prevention of hospitalization in older adults

10.1056/nejmoa2509810 · ExternalCitation · doi-reference

Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature

10.1086/525263 · ExternalCitation · doi-reference

Efficacy, immunogenicity, and safety of the bivalent respiratory syncytial virus (RSV) prefusion F (RSVpreF) vaccine in older adults over 2 RSV seasons

10.1093/cid/ciaf061 · ExternalCitation · doi-reference

Severe morbidity and mortality associated with respiratory syncytial virus versus influenza infection in hospitalized older adults

10.1093/cid/ciy991 · ExternalCitation · doi-reference

A phase 1/2 study of a respiratory syncytial virus prefusion F vaccine with and without adjuvant in healthy older adults

10.1093/infdis/jiac189 · ExternalCitation · doi-reference

Incidence of respiratory syncytial virus-associated hospitalization among adults in Ontario, Canada, 2017–2019

10.1093/infdis/jiaf343 · ExternalCitation · doi-reference

Global disease burden estimates of respiratory syncytial virus-associated acute respiratory infection in older adults in 2015: a systematic review and meta-analysis

10.1093/infdis/jiz059 · ExternalCitation · doi-reference

Systematic literature review of risk factors for poor outcomes among adults with respiratory syncytial virus infection in high-income countries

10.1093/ofid/ofad513 · ExternalCitation · doi-reference

Epidemiology and immediate indirect effects of respiratory viruses in lung transplant recipients: a 5-year prospective study

10.1111/ajt.14042 · ExternalCitation · doi-reference

The Danish civil registration system

10.1177/1403494810387965 · ExternalCitation · doi-reference

Impact of RSV infection in transplant and immunocompromised population: incidence and co-infections: retrospective analysis of a single centre

10.3390/jcm14134803 · ExternalCitation · doi-reference

Immunogenicity and safety of the bivalent respiratory syncytial virus prefusion F subunit vaccine in immunocompromised or renally impaired adults

10.3390/vaccines13030328 · ExternalCitation · doi-reference

Neutralizing antibody response to the AreXvy respiratory syncytial virus vaccine in lung transplant recipients: assessment against reference and seasonal strains

10.3390/vaccines13040398 · ExternalCitation · doi-reference